FDA
approval
· 2025-02-19
FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved a supplemental application for Fluphenazine Decanoate by Hikma Pharmaceuticals USA Inc. for continued marketing of this long-acting injectable anti…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FLUPHENAZINE DECANOATE (FLUPHENAZINE DECANOATE)